MagIA is developing a multi-analyis "Point-of-Care" that can be used outside of any clinical environment. With a first focus on infectious diseases MagIA is providing a syndromic testing approach at the Point of Care outside of traditional clinical environment. With the motto “a better screening for a better care", MagIA focuses first on the rapid detection of infectious diseases, starting with an HIV-Viral Hepatitis combo, to link to care Key « high-risk » populations. MagIA's innovation is a one-step no-wash immunoassay method which brings unique characteristics: (1) laboratory quality on a portable device, usable indoor, outdoor, (2) 8 analyses in parallel with 1 single fingerpick, for a syndromic diagnostic approach (3) secured analysis and traceable results.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Grenoble, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- magia-diagnostics.com
- Keywords
- Comptable - FIRE Consultant.
- HQ
- Grenoble
Magia Diagnostics Questions
Magia Diagnostics's website is magia-diagnostics.com
Magia Diagnostics's LinkedIn profile is https://fr.linkedin.com/company/magia-diagnostics
Magia Diagnostics has
19 employees.
View email and phone details for 19
employees at Magia Diagnostics.
Magia Diagnostics's industry is
Biotechnology Research
Magia Diagnostics's top competitors are
Cell&soft,
Cytoo,
Glycobar,
Inovotion,
Lxrepair 2013-2023,
Avalun,
Biotechni Sas,
Genel,
Somno Engineering,
Pelican Health.
Magia Diagnostics's categories are Biotechnology Research
Magia Diagnostics's founding year is 2017
